ImmunityBio (IBRX) Intangibles (2013 - 2024)
ImmunityBio (IBRX) reported Intangibles of $16.1 million for Q2 2024, down 15.45% year-over-year from $19.0 million in Q3 2023, and down 3.1% on a QoQ basis from $16.6 million in Q1 2024.
ImmunityBio (IBRX) has 11 years of Intangibles data on file, last reported at $16.1 million in Q2 2024.
- Quarterly Intangibles fell 15.45% year-over-year to $16.1 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $16.1 million (down 15.45% YoY) and the FY2023 annual result came in at $17.1 million, down 14.55% from the prior year.
- Intangibles retreated to $16.1 million in Q2 2024 per IBRX's latest filing, from $16.6 million in the prior quarter.
- Across five years, Intangibles topped out at $22.3 million in Q1 2022 and bottomed at $1.4 million in Q4 2021.
- The 5-year median for Intangibles is $17.1 million (2023), against an average of $13.2 million.
- The widest annual swing landed in 2022, when Intangibles surged 1454.17%; it then dropped 15.45% in 2024.
- Tracing IBRX's Intangibles over 5 years: stood at $1.5 million in 2020, then fell by 2.94% to $1.4 million in 2021, then surged by 1308.66% to $20.0 million in 2022, then decreased by 14.55% to $17.1 million in 2023, then retreated by 6.06% to $16.1 million in 2024.
- Per Business Quant, the three latest IBRX Intangibles figures stand at $16.1 million (Q2 2024), $16.6 million (Q1 2024), and $17.1 million (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 4.41 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 11,640.44 |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 418.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.29 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 16.06 Mn |
| Mar 31, 2024 | 16.57 Mn |
| Dec 31, 2023 | 17.09 Mn |
| Sep 30, 2023 | 18.47 Mn |
| Jun 30, 2023 | 18.99 Mn |
| Mar 31, 2023 | 19.50 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Sep 30, 2022 | 20.47 Mn |
| Jun 30, 2022 | 21.74 Mn |
| Mar 31, 2022 | 22.35 Mn |
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 1.43 Mn |
| Jun 30, 2021 | 1.45 Mn |
| Mar 31, 2021 | 1.44 Mn |
| Dec 31, 2020 | 1.46 Mn |
| Dec 31, 2018 | 565,000.00 |
| Sep 30, 2018 | 1.13 Mn |
| Jun 30, 2018 | 1.70 Mn |
| Mar 31, 2018 | 2.26 Mn |
| Dec 31, 2017 | 2.83 Mn |
| Sep 30, 2017 | 3.39 Mn |
| Jun 30, 2017 | 3.96 Mn |
| Mar 31, 2017 | 4.52 Mn |
| Dec 31, 2016 | 5.09 Mn |
| Sep 30, 2016 | 5.95 Mn |
| Jun 30, 2016 | 6.40 Mn |
| Mar 31, 2016 | 6.84 Mn |
| Dec 31, 2015 | 7.29 Mn |
| Sep 30, 2015 | 6.28 Mn |
| Jun 30, 2015 | 7.62 Mn |
| Mar 31, 2015 | -856,000.00 |
| Dec 31, 2014 | 835,000.00 |
| Sep 30, 2014 | -840,000.00 |
| Jun 30, 2014 | -818,000.00 |
| Mar 31, 2014 | 794,000.00 |
| Dec 31, 2013 | 3,000.00 |